A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive care unit (MelCOVID study): a structured summary of a study protocol for a randomized controlled trial.

ABSTRACT:

SUBMITTER: Rodriguez-Rubio M 

PROVIDER: S-EPMC7403786 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature